Protalix Biotherapeutics raised €36M in a funding round in Dec 2020. The company is based in Carmiel, Israel. Data as of Nov 2026.
Amount raised
€36M
€36,217,471
Native amount
43,700,000 USD
Stage
Other
Investors
0
Provenance & confidence
High confidenceAmount
43,700,000 USD
ECB-at-date → €36M · rate 1.2066 on 2020-12-02
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
Dec 2020
Round type
—
Amount (EUR)
€36M
Other rounds
same companyThis is the company's only recorded round.